Načítá se...
Incretin-Based Therapy for Diabetes: What a Cardiologist Needs to Know
Incretin-based therapies are effective glucose-lowering drugs that have an increasing role in the treatment of type 2 diabetes, due to their efficacy, safety, and ease of use. Both glucagon-like peptide-1 receptor agonists (GLP-1Ra) and dipeptidyl peptidase-4 inhibitors (DPP-4i) are commonly used fo...
Uloženo v:
| Vydáno v: | J Am Coll Cardiol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861061/ https://ncbi.nlm.nih.gov/pubmed/27012410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2015.12.058 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|